 TARRYTOWN, N.Y., Jan. 03, 2023 GLOBE NEWSWIRE -- Regeneron Pharmaceuticals, Inc. NASDAQ: REGN today announced that it will report its fourth quarter and full year 2022 financial and operating results on Friday, February 3, 2023, before the U.S. financial markets open. The Company will host a conference call and simultaneous webcast at 8:30 AM Eastern Time that day. 